Webcast is Live at 7:30 a.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Nov. 4, 2015--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and
in vitro diagnostic technologies to the healthcare industry, announced
today that it will host a live webcast of its fourth quarter and fiscal
year 2015 conference call on Tuesday, November 10, at 7:30 a.m. CT (8:30
a.m. ET). The Company will issue an earnings news release earlier that
morning.
Gary Maharaj, president and chief executive officer, and Andy LaFrence,
vice president of finance and chief financial officer, will recap the
fourth quarter and fiscal year 2015 financial results and
accomplishments. To access the webcast, go to the investor relations
portion of the Company’s website at www.surmodics.com
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 10:30 a.m. CT on Tuesday,
November 10, until 10:30 a.m. CT on Tuesday, November 17, and can be
accessed by dialing 888-203-1112 and entering conference call ID
passcode 944630. In addition, the conference call audio and transcript
will be archived on the Company’s website following the call.
About SurModics, Inc.
SurModics partners with the world's
leading and emerging medical device, diagnostic and life sciences
companies to develop and commercialize innovative products designed to
improve lives by enabling the detection and treatment of disease. Our
mission is to be a trusted partner to our customers by providing the
most advanced surface modification technologies and in vitro
diagnostic chemical components that help enhance the well-being of
patients. The company’s core offerings include surface modification
coating technologies that impart lubricity, prohealing and
biocompatibility characteristics and components for in vitro
diagnostic test kits and microarrays. SurModics is headquartered in Eden
Prairie, Minnesota. For more information about the Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151104005395/en/
Source: SurModics, Inc.
SurModics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com